bronchospasm articles & resources on Made-in-China.com

FDA Has Approved GSK and Theravance's Anoro Ellipta

Dec 20, 2013

The US Food and Drug Administration (FDA) has approved GlaxoSmithKline (GSK) and Theravance's Anoro Ellipta as a once-daily, long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease ...

Tags: GSK, COPD Drug

GSK and Theravance Reaveals The Availability of Breo Ellipta

Nov 4, 2013

UK-based GlaxoSmithKline (GSK) and US-based Theravance have announced the availability of BREO ELLIPTA, a once-daily prescription medicine for chronic obstructive pulmonary disease (COPD), in the US pharmacies. BREO ELLIPTA is a ...

Tags: Health, Medicine

Grupo Ferrer Internacional Has Begun Sales of Adasuve Inhalation Powder

Aug 2, 2013

Grupo Ferrer Internacional, Alexza Pharmaceuticals' commercial partner, has begun sales of Adasuve inhalation powder, pre-dispensed (Staccato Loxapine) in the European Union (EU). The first sale triggered a $1.25m milestone payment to ...

Tags: Inhalation Powder, Grupo

FDA Has Approved New Drug Application for Generic Xopenex Inhalation Solution

Mar 20, 2013

The US Food and Drug Administration (FDA) has approved Mylan Specialty's abbreviated new drug application for the generic equivalent to Sunovion's Xopenex inhalation solution, Levalbuterol inhalation solution USP, 0.31mg/3mL (0.0103%), ...

Tags: FDA, Mylan, Drug

The FDA Approved Long-Acting Anticholinergic Was Indicated

Dec 14, 2012

Forest Laboratories and Almirall have announced the commercial availability of anticholinergic agent Tudorza Pressair in 400mcg dose strength, in the US pharmacies. The FDA approved long-acting anticholinergic was indicated for the ...

Tags: anticholinergic agent, pharmacies, multidose, Almirall, medicine

Watson Has Introduced Authorized Generic Version of Xopenex Inhalation Solution

Nov 28, 2012

Watson Pharmaceuticals has introduced authorized generic version of Xopenex (levalbuterol HCl) inhalation solution and begun the shipment of the product. Xopenex inhalation solution indicated for the treatment or prevention of ...

Tags: Xopenex inhalation solution, bronchospasm, Sunovion Pharmaceuticals

American Regent Has Issued a Retail/Hospital Level Recall of Epinephrine Injection

Nov 28, 2012

American Regent has issued a retail/hospital level recall of Epinephrine Injection, USP, because of discoloration and small visible particles found in some ampules of lot #1395. The adverse events after intravenous administration of ...

Tags: Epinephrine Injection, USP, Luitpold Pharmaceuticals, American Regent

Sunovion Lodged a Suit Against Watson for US Patents

Jun 15, 2012

Watson Pharmaceuticals said Sunovion Pharmaceuticals has challenged Watson Laboratories filing of Abbreviated New Drug Application(ANDA)with the US Food and Drug Administration(FDA)seeking approval for marketing Levalbuterol Tartrate ...

Tags: Sunovion, FDA, Watson Laboratories

bronchospasm

Related Products